Venetoclax does not prolong the QT interval in patients with hematological malignancies: an exposure–response analysis
Crossref DOI link: https://doi.org/10.1007/s00280-016-3144-1
Published Online: 2016-09-01
Published Print: 2016-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Freise, Kevin J.
Dunbar, Martin
Jones, Aksana K.
Hoffman, David
Enschede, Sari L. Heitner
Wong, Shekman
Salem, Ahmed Hamed http://orcid.org/0000-0002-9261-1583
Funding for this research was provided by:
AbbVie
Genentech
License valid from 2016-09-01